Literature DB >> 17298655

Allocation of substance use disorder patients to appropriate levels of care: feasibility of matching guidelines in routine practice in Dutch treatment centres.

Maarten J M Merkx1, Gerard M Schippers, Maarten J W Koeter, Pieter Jelle Vuijk, Suzan Oudejans, Carlijn C Q de Vries, Wim van den Brink.   

Abstract

AIMS: To examine the feasibility of implementing evidence-based guidelines for patient-treatment-matching to levels of care in two Dutch substance abuse treatment centres.
DESIGN: Multi-centre observational follow-up study.
SETTING: Two large substance abuse treatment centres (SATCs). PARTICIPANTS: All 4394 referrals to the two SATCs in 2003. MEASUREMENTS: Baseline patient characteristics needed for treatment allocation according to protocol, treatment allocation according to matching protocol, treatment allocation according to actual level of care (LOC) entered. ANALYSIS: Comparison of recommended and actual LOC entered. Evaluation of reasons for observed differences between recommended and actual LOC entered.
FINDINGS: Data needed for treatment allocation according to protocol were available for 2269 (51.6%) patients. Data needed for evaluation of actual LOC entered were available for 1765 (40.2%) patients. Of these patients, 1089 (60.8%) were allocated according to protocol: 48.4% based on the guideline algorithm and 12.4% based on clinically justified deviations from this algorithm. The main reason for deviation was a different appraisal of addiction severity, made by the intake counsellor compared to the protocol.
CONCLUSION: The feasibility of guideline-based treatment allocation is seriously limited due to inadequate data collection of patient characteristics and suboptimal guideline-based treatment allocation. As a consequence, only 24.4% of the patients could be evaluated as being matched properly to the treatment planned. The results indicate several barriers which limit the adequate implementation of patient-treatment-matching guidelines: problems in the infrastructure of data collection and storage and the inertia of intake staff who did not adhere to the guidelines for assessment and matching.

Entities:  

Mesh:

Year:  2007        PMID: 17298655     DOI: 10.1111/j.1360-0443.2006.01716.x

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  5 in total

1.  Application of multivariate probabilistic (Bayesian) networks to substance use disorder risk stratification and cost estimation.

Authors:  Lawrence Weinstein; Todd A Radano; Timothy Jack; Philip Kalina; John S Eberhardt
Journal:  Perspect Health Inf Manag       Date:  2009-09-16

2.  High-risk offenders participating in court-supervised substance abuse treatment: characteristics, treatment received, and factors associated with recidivism.

Authors:  Elizabeth Evans; David Huang; Yih-Ing Hser
Journal:  J Behav Health Serv Res       Date:  2011-10       Impact factor: 1.505

3.  Placement matching of alcohol-dependent patients based on a standardized intake assessment: rationale and design of a randomized controlled trial.

Authors:  Angela Buchholz; Anke Friedrichs; Michael Berner; Hans-Helmut König; Alexander Konnopka; Ludwig Kraus; Levente Kriston; Heinrich Küfner; Daniela Piontek; Fred Rist; Jeanette Röhrig
Journal:  BMC Psychiatry       Date:  2014-10-14       Impact factor: 3.630

4.  Is treatment outcome improved if patients match themselves to treatment options? Study protocol for a randomized controlled trial.

Authors:  Morten Ellegaard Hell; William R Miller; Bent Nielsen; Anette Søgaard Nielsen
Journal:  Trials       Date:  2018-04-06       Impact factor: 2.279

5.  Patient-centered placement matching of alcohol-dependent patients based on a standardized intake assessment: process evaluation within an exploratory randomized controlled trial.

Authors:  Angela Buchholz; Michael Berner; Judith Dams; Anke Rosahl; Jochen Hempleman; Hans-Helmut König; Alexander Konnopka; Levente Kriston; Daniela Piontek; Jens Reimer; Jeanette Röhrig; Norbert Scherbaum; Anna Silkens; Ludwig Kraus
Journal:  BMC Psychiatry       Date:  2022-01-27       Impact factor: 3.630

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.